| Villarini M, Moretti M, Fatigoni C, et al.
Evaluation of Primary DNA Damage, Cytogenetic Biomarkers and Genetic Polymorphisms for CYP1A1 and GSTM1 in Road Tunnel Construction Workers. [Journal Article]
J Toxicol Environ Health A 2008; 71(21):1430-9.
Abstract | Full Citation | | Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, et al.
Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. [Journal Article]
J Toxicol Environ Health A 2008; 71(21):1415-29.
Abstract | Full Citation | | Lin YH, Peng FC
Predicting the Contribution of Rat Cytochrome P-450 3A1, 3A2 and Human Cytochrome P-450 3A4, 3A5 to Territrem a 4beta-C Hydroxylation Using the Relative Activity Factor. [Journal Article]
J Toxicol Environ Health A 2008; 71(21):1407-14.
Abstract | Full Citation | | Newman WG, Hadfield KD, Latif A, et al.
Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. [Journal Article]
Clin Cancer Res 2008 Sep 15; 14(18):5913-8.
Abstract | Full Citation | Find Related Articles | | Goetz MP, Suman VJ, Couch FJ, et al.
Cytochrome P450 2D6 and Homeobox 13/Interleukin-17B Receptor: Combining Inherited and Tumor Gene Markers for Prediction of Tamoxifen Resistance. [Journal Article]
Clin Cancer Res 2008 Sep 15; 14(18):5864-8.
Abstract | Full Citation | Find Related Articles | | Shord1 SS, Cavallari1 LH, M , et al.
Cytochrome P450 2C9 mediated metabolism in people with and without cancer. [JOURNAL ARTICLE]
Int J Clin Pharmacol Ther 2008 Jul; Volume 46(July):365-374.
Abstract | Full Citation | | Li L, Chang Z, Pan Z, et al.
Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase. [Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]
Proc Natl Acad Sci U S A 2008 Sep 16; 105(37):13883-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Louw VJ, Louw H
Citrus aurantium--beware of the bitter orange. [Comment, Letter]
S Afr Med J 2008 Jul; 98(7):496.
Full Citation | Find Related Articles | | Gurwitz D, Newman W
Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. [Comment, Letter]
J Natl Cancer Inst 2008 Sep 17; 100(18):1331; author reply 1332-4.
Full Citation | Publisher Full Text | Find Related Articles | | Chlebowski RT, Col N
Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. [Comment, Letter]
J Natl Cancer Inst 2008 Sep 17; 100(18):1331-2; author reply 132-3.
Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
